Table 4. Median differences of ARAT, FMA-UE and DASH scores from baseline (T0) to post-treatment visit (T3).
| Test | Time | M-TOT (N = 32) | C-TOT (N = 36) | p-value (treatment) | p-value (visit) | p-value (treatment*visit) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Median | IQR | N | Median | IQR | |||||
| ARAT | T1 | 31 | 0.0 | 0.0;5.0 | 34 | 0.0 | 0.0;2.0 | |||
| T2 | 32 | 2.0 | 0.0;11.0 | 33 | 1.0 | 0.0;7.0 | ||||
| T3 | 32 | 3.0 | 0.0;12.5 | 36 | 2.0 | 0.0;9.5 | 0.77 | <0.0001 | 0.27 | |
| FMA-UE | T3 | 32 | 4.5 | 1.5;14.0 | 36 | 3.5 | 0.5;6.5 | 0.58 | <0.0001 | 0.07 |
| DASH | T3 | 32 | -4.5 | -11.4;1.5 | 34 | -4.8 | -14.0;0 | 0.07 | <0.0001 | 0.32 |
M-TOT: Myoelectric control of functional electrical stimulation-task oriented training; C-TOT: control-task oriented training; IQR: interquartile range. ARAT: action research arm test; FMA-UE: Fugl Meyer assessment for the upper limbs; DASH: disability of the arm, shoulder and hand questionnaire.T0: baseline visit; T1: after 8 rehabilitation sessions; T2: after 16 rehabilitation sessions; T3: post-treatment visit (after 25 rehabilitation sessions, 6–7 weeks). p-values for treatment effect (differences between treatment arms), visit effect (differences between visits) and treatment*visit interaction (differences in the change over time between treatment arms) were obtained from a multivariable repeated measures mixed model, adjusting by stroke chronicity and rehabilitation center.